News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to…
The Taiwan National Lung Cancer Early Detection Program detected 85 percent of lung cancer cases…
A study presented at the International Association for the Study of Lung Cancer 2023 World…
The stigma that patients face when diagnosed with lung cancer is associated with poorer psychosocial…
The combination of benmelstobart, anlotinib, and chemotherapy demonstrated significant benefits compared to placebo and chemotherapy…
Scientists at City of Hope, USA, have identified a cell metabolism process found in men…
The American Society of Clinical Oncology (ASCO) has issued updated guidelines for geriatric oncology, outlining…
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group recently held another…
Q&A with Meeting Co-Convenor Dr Ben Lawrence, Head of Oncology at University of Auckland &…
Q&A with Meeting Co-Convenor Dr Ben Lawrence, Head of Oncology at University of Auckland &…